Coeptis Therapeutics Correlations

COEP Stock

USD 9.43 0.03 0.32%

The current 90-days correlation between Coeptis Therapeutics and Sonnet Biotherapeutics Holdings is 0.23 (i.e., Modest diversification). The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Coeptis Therapeutics Correlation With Market

Good diversification

The correlation between Coeptis Therapeutics and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Coeptis Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.

Moving together with Coeptis Stock

0.63	VALN	Valneva SE ADR	Pair Corr
0.75	MIRM	Mirum Pharmaceuticals	Pair Corr
0.65	VERV	Verve Therapeutics	Pair Corr
0.73	MNPR	Monopar Therapeutics Earnings Call This Week	Pair Corr

Moving against Coeptis Stock

0.62	MBIO	Mustang Bio	Pair Corr
0.6	MDXG	MiMedx Group	Pair Corr
0.5	MCRB	Seres Therapeutics	Pair Corr
0.49	MGNX	MacroGenics	Pair Corr
0.39	MBRX	Moleculin Biotech Earnings Call Today	Pair Corr
0.31	VANI	Vivani Medical Earnings Call This Week	Pair Corr
0.72	MNKD	MannKind Corp	Pair Corr
0.7	DSGN	Design Therapeutics Potential Growth	Pair Corr
0.62	VERA	Vera Therapeutics	Pair Corr
0.61	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.49	DRMA	Dermata Therapeutics	Pair Corr
0.41	MLEC	Moolec Science SA	Pair Corr
0.38	MLYS	Mineralys Therapeutics, Trending	Pair Corr
0.83	MRKR	Marker Therapeutics Earnings Call This Week	Pair Corr
0.8	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.69	DYAI	Dyadic International Earnings Call This Week	Pair Corr
0.63	VKTX	Viking Therapeutics	Pair Corr

Related Correlations Analysis

	ICU	VIRI	ZVSA	SONN	REVB	CMND	HILS	MGTA	QNRX	GNLX
ICU		0.0	-0.32	-0.22	0.22	0.08	0.0	0.0	0.31	-0.35	ICU
VIRI	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	VIRI
ZVSA	-0.32	0.0		0.68	0.39	0.74	0.0	0.0	0.04	-0.08	ZVSA
SONN	-0.22	0.0	0.68		0.39	0.54	0.0	0.0	0.15	-0.07	SONN
REVB	0.22	0.0	0.39	0.39		0.66	0.0	0.0	0.61	-0.64	REVB
CMND	0.08	0.0	0.74	0.54	0.66		0.0	0.0	0.35	-0.36	CMND
HILS	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	HILS
MGTA	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	MGTA
QNRX	0.31	0.0	0.04	0.15	0.61	0.35	0.0	0.0		-0.66	QNRX
GNLX	-0.35	0.0	-0.08	-0.07	-0.64	-0.36	0.0	0.0	-0.66		GNLX
	ICU	VIRI	ZVSA	SONN	REVB	CMND	HILS	MGTA	QNRX	GNLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CMND	+ 0.74	ZVSA
SONN	+ 0.68	ZVSA
CMND	+ 0.66	REVB
QNRX	+ 0.61	REVB
CMND	+ 0.54	SONN
REVB	+ 0.39	ZVSA

High negative correlations

GNLX	- 0.66	QNRX
GNLX	- 0.64	REVB
GNLX	- 0.36	CMND
GNLX	- 0.35	ICU
ZVSA	- 0.32	ICU
SONN	- 0.22	ICU

Risk-Adjusted Indicators

There is a big difference between Coeptis Stock performing well and Coeptis Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Coeptis Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ICU	3.60	0.24	0.05	0.19	4.33	(4.34)	7.45	(5.71)	45.71
VIRI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ZVSA	4.29	(0.46)	0.00	(0.98)	0.00	0.00	10.11	(8.20)	38.26
SONN	3.41	0.01	0.00	(0.06)	0.00	0.00	8.57	(6.32)	44.37
REVB	5.79	(0.62)	0.00	0.13	0.00	0.00	11.78	(12.26)	66.25
CMND	3.65	0.23	0.05	0.07	3.52	(5.10)	6.25	(5.70)	50.29
HILS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MGTA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
QNRX	5.50	(1.14)	0.00	2.46	0.00	0.00	14.29	(10.53)	57.78
GNLX	5.40	1.25	0.23	1.12	4.76	(7.15)	12.60	(10.00)	36.53

Coeptis Therapeutics Corporate Management

Daniel Yerace	VP CoFounder	Profile
Gary Conte	VP Marketing	Profile
David Mehalick	Chairman, CoFounder	Profile
Brian MBA	Chief Officer	Profile
MSc MD	CSO Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC